Abstract:ABSTRACT The induction of systemic antibody titers against hemagglutinin has long been the main focus of influenza vaccination strategies, but mucosal immunity has also been shown to play a key role in the protection against respiratory viruses. By vaccinating and challenging healthy volunteers, we demonstrated that inactivated influenza vaccine (IIV) modestly reduced the rate of influenza while predominantly boosting serum antibody titers against hemagglutinin (HA) and HA stalk, a consequence of the low neuraminidase (NA) content of IIV and the intramuscular route of administration. The viral challenge induced nasal and serum responses against both HA and NA. Correlations between mucosal IgA and serum IgG against specific antigens were low, whether before or after challenge, suggesting a compartmentalization of immune responses. Even so, volunteers who developed viral shedding for multiple days had lower baseline titers across both systemic and mucosal compartments as compared to those with no shedding or a single day of shedding. Regression analysis showed that pre-challenge HA inhibition titers were the most consistent correlate of protection across clinical outcomes combining shedding and symptoms, with NA inhibition titers and HA IgG levels only predicting the duration of shedding. Despite the inclusion of data from multiple binding and functional antibody assays against HA and NA performed on both serum and nasal samples, multivariate models were unable to account for the variability in outcomes, emphasizing our imperfect understanding of immune correlates in influenza and the importance of refining models with assessments of innate and cellular immune responses. IMPORTANCE The devastating potential of influenza has been well known for over 100 years. Despite the development of vaccines since the middle of the 20th century, influenza continues to be responsible for substantial global morbidity and mortality. To develop next-generation vaccines with enhanced effectiveness, we must synthesize our understanding of the complex immune mechanisms culminating in protection. Our study outlines the differences in immune responses to influenza vaccine and influenza infection, identifying potential gaps in vaccine-induced immunity, particularly at the level of the nasal mucosa. Furthermore, this research underscores the need to refine our imperfect models while recognizing potential pitfalls in past and future attempts to identify and measure correlates of protection.

The response to influenza vaccination is associated with DNA methylation-driven regulation of T cell innate antiviral pathways

Longitudinal analysis of influenza vaccination implicates regulation of RIG-I signaling by DNA methylation

System-Wide Associations between DNA-Methylation, Gene Expression, and Humoral Immune Response to Influenza Vaccination

Single-nucleotide methylation specifically represses type I interferon in antiviral innate immunity

Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses

Increasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct.

Prevaccination Glycan Markers of Response to an Influenza Vaccine Implicate the Complement Pathway

Epigenetic Variation Impacts Individual Differences in the Transcriptional Response to Influenza Infection

Systemic dysregulation and molecular insights into poor influenza vaccine response in the aging population

Influenza vaccination features revealed by a single‐cell transcriptome atlas

Transcriptomic Analysis Reveals Sixteen Potential Genes Associated with the Successful Differentiation of Antibody-Secreting Cells through the Utilization of Unfolded Protein Response Mechanisms in Robust Responders to the Influenza Vaccine

Effect of Lymphocyte miRNA Expression on Influenza Vaccine-Induced Immunity

The Metabolic Hormone Leptin Promotes the Function of TFH Cells and Supports Vaccine Responses

Cell-Mediated Proteomics, and Serological and Mucosal Humoral Immune Responses after Seasonal Influenza Immunization: Characterization of Serological Responders and Non-Responders

[Association of DNA methylation of IFNG gene with no/low response to hepatitis B vaccine in children]

Leveraging baseline transcriptional features and information from single-cell data to power the prediction of influenza vaccine response

Influenza Vaccination Mediates SARS-CoV-2 Spike Protein Peptide-Induced Inflammatory Response via Modification of Histone Acetylation

Host response to influenza infections in human blood: association of influenza severity with host genetics and transcriptomic response

Innate immune epigenomic landscape following controlled human influenza virus infection

Psychosocial predictors of the innate immune response to influenza vaccination

Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers